Trial Outcomes & Findings for Harmonic ACE®+7 Shears in Laparoscopic Colectomy (NCT NCT02248246)

NCT ID: NCT02248246

Last Updated: 2016-07-29

Results Overview

Hemostasis of the IMA is a dichotomous variable (i.e. yes or no). "Yes" is defined as a single activation of the Advanced Hemostasis Mode to transect and seal the IMA.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

40 participants

Primary outcome timeframe

Intraoperatively

Results posted on

2016-07-29

Participant Flow

Participant milestones

Participant milestones
Measure
Colectomy With Harmonic ACE®+7 Shears
Laparoscopic colectomy with Harmonic ACE®+7 Shears for dissection and vessel transection Harmonic ACE®+7 Shears: Vessel sealing performance assessed for transection and sealing of the following named vessels: * Inferior mesenteric artery (IMA) * Inferior mesenteric vein (IMV) (if identified)
Overall Study
STARTED
40
Overall Study
COMPLETED
40
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Harmonic ACE®+7 Shears in Laparoscopic Colectomy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Colectomy With Harmonic ACE®+7 Shears
n=40 Participants
Laparoscopic colectomy with Harmonic ACE®+7 Shears for dissection and vessel transection Harmonic ACE®+7 Shears: Vessel sealing performance assessed for transection and sealing of the following named vessels: * Inferior mesenteric artery (IMA) * Inferior mesenteric vein (IMV) (if identified)
Age, Continuous
59.8 years
STANDARD_DEVIATION 13.3 • n=5 Participants
Sex: Female, Male
Female
24 Participants
n=5 Participants
Sex: Female, Male
Male
16 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
40 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
Belgium
15 participants
n=5 Participants
Region of Enrollment
United States
14 participants
n=5 Participants
Region of Enrollment
United Kingdom
11 participants
n=5 Participants

PRIMARY outcome

Timeframe: Intraoperatively

Population: Safety Set - all subjects in whom the procedure was started.

Hemostasis of the IMA is a dichotomous variable (i.e. yes or no). "Yes" is defined as a single activation of the Advanced Hemostasis Mode to transect and seal the IMA.

Outcome measures

Outcome measures
Measure
Colectomy With Harmonic ACE®+7 Shears
n=40 Participants
Laparoscopic colectomy with Harmonic ACE®+7 Shears for dissection and vessel transection Harmonic ACE®+7 Shears: Vessel sealing performance assessed for transection and sealing of the following named vessels: * Inferior mesenteric artery (IMA) * Inferior mesenteric vein (IMV) (if identified)
Percentage of Participants With Hemostasis at the IMA
100.0 percentage of subjects
Interval 91.2 to 100.0

SECONDARY outcome

Timeframe: Intraoperatively

Population: Safety Set - all subjects in whom the procedure was started.

Hemostasis of the IMV is a dichotomous variable (i.e. yes or no). "Yes" is defined as a single activation of the Advanced Hemostasis Mode to transect and seal the IMV.

Outcome measures

Outcome measures
Measure
Colectomy With Harmonic ACE®+7 Shears
n=40 Participants
Laparoscopic colectomy with Harmonic ACE®+7 Shears for dissection and vessel transection Harmonic ACE®+7 Shears: Vessel sealing performance assessed for transection and sealing of the following named vessels: * Inferior mesenteric artery (IMA) * Inferior mesenteric vein (IMV) (if identified)
Percentage of Participants With Hemostasis at the IMV
97.5 percentage of participants
Interval 86.8 to 99.9

Adverse Events

Colectomy With Harmonic ACE®+7 Shears

Serious events: 5 serious events
Other events: 20 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Colectomy With Harmonic ACE®+7 Shears
n=40 participants at risk
Laparoscopic colectomy with Harmonic ACE®+7 Shears for dissection and vessel transection Harmonic ACE®+7 Shears: Vessel sealing performance assessed for transection and sealing of the following named vessels: * Inferior mesenteric artery (IMA) * Inferior mesenteric vein (IMV) (if identified)
Blood and lymphatic system disorders
Anemia
2.5%
1/40 • Number of events 1
Gastrointestinal disorders
Small intestinal obstruction
5.0%
2/40 • Number of events 2
Injury, poisoning and procedural complications
Gastrointestinal anastomotic leak
2.5%
1/40 • Number of events 1
Injury, poisoning and procedural complications
Postoperative ileus
5.0%
2/40 • Number of events 2
Injury, poisoning and procedural complications
Procedural haemorrhage
2.5%
1/40 • Number of events 1
Injury, poisoning and procedural complications
Splenic haematoma
2.5%
1/40 • Number of events 1

Other adverse events

Other adverse events
Measure
Colectomy With Harmonic ACE®+7 Shears
n=40 participants at risk
Laparoscopic colectomy with Harmonic ACE®+7 Shears for dissection and vessel transection Harmonic ACE®+7 Shears: Vessel sealing performance assessed for transection and sealing of the following named vessels: * Inferior mesenteric artery (IMA) * Inferior mesenteric vein (IMV) (if identified)
Gastrointestinal disorders
Nausea
22.5%
9/40
Gastrointestinal disorders
Vomiting
10.0%
4/40
General disorders
Pain
17.5%
7/40
Infections and infestations
Wound infection
5.0%
2/40
Injury, poisoning and procedural complications
Procedural pain
10.0%
4/40

Additional Information

Michael Schwiers

Ethicon

Phone: 513-337-1172

Results disclosure agreements

  • Principal investigator is a sponsor employee The PIs agreed that the first publication of results should be made in conjunction with the presentation of a joint, multicenter publication of the results with all PIs contributing data, analyses, and comments. If this publication was not submitted within 12 months after conclusion of the Study at all sites, or after Sponsor confirmed there would be no multicenter Study publication, whichever is first, the PIs could have published the results from their individual sites.
  • Publication restrictions are in place

Restriction type: OTHER